Latest Articles
Whitehawk’s HWK-016 ADC Trial Advances in Tough Ovarian and Endometrial Cancers - TipRanks
Whitehawk’s HWK-016 ADC Trial Advances in Tough Ovarian and Endometrial Cancers TipRanks
Published: Aug. 6, 2026, 6:39 p.m.
Weight-loss drugs linked to lower cancer risk in obese people without diabetes - Nature
Weight-loss drugs linked to lower cancer risk in obese people without diabetes Nature
Published: Aug. 6, 2026, 2:09 p.m.
Sentinel Node Biopsy Gains Ground in Endometrial Cancer - Medscape
Sentinel Node Biopsy Gains Ground in Endometrial Cancer Medscape
Published: Aug. 6, 2026, 12:34 p.m.
Sentinel Node Biopsy Gains Ground in Endometrial Cancer - medscape.com
Sentinel Node Biopsy Gains Ground in Endometrial Cancer medscape.com
Published: Aug. 6, 2026, 12:34 p.m.
Ga. woman files lawsuit after cancer misdiagnosis leads to unnecessary hysterectomy - WRDW
Ga. woman files lawsuit after cancer misdiagnosis leads to unnecessary hysterectomy WRDW
Published: Aug. 6, 2026, 1:05 a.m.
UBC researchers awarded major grants to advance precision cancer research - UBC Faculty of Medicine
UBC researchers awarded major grants to advance precision cancer research UBC Faculty of Medicine
Published: Aug. 5, 2026, 11:42 p.m.
Georgia Woman Sues Kaiser Permanente Over False Cancer Diagnosis and Unnecessary Hysterectomy - Law Commentary
Georgia Woman Sues Kaiser Permanente Over False Cancer Diagnosis and Unnecessary Hysterectomy Law Commentary
Published: Aug. 5, 2026, 3:05 p.m.
Georgia Woman Sues Kaiser Permanente Over False Cancer Diagnosis and Unnecessary Hysterectomy - lawcommentary.com
Georgia Woman Sues Kaiser Permanente Over False Cancer Diagnosis and Unnecessary Hysterectomy lawcommentary.com
Published: Aug. 5, 2026, 3:05 p.m.
A drug for endometriosis and breast cancer is being pulled from Australia - RUSSH
A drug for endometriosis and breast cancer is being pulled from Australia RUSSH
Published: Aug. 5, 2026, 8:36 a.m.
Molecular profiling identifies favorable risk pattern in rare, aggressive uterine cancer - Bioengineer.org
Molecular profiling identifies favorable risk pattern in rare, aggressive uterine cancer Bioengineer.org
Published: Aug. 4, 2026, 11:03 p.m.
Link copied to clipboard!